William H. Shrank, MD, MSHS

home / authors / william-h-shrank-md-mshs

Articles

Outcomes of a Specialty Pharmacy Program for Oral Oncology Medications

Suzanne J. Tschida, PharmD, BCPS;Saad Aslam, PhD;Lincy S. Lal, PhD, PharmD;Tanvir T. Khan, MSc;William H. Shrank, MD, MSHS;Gandhi R. Bhattarai, PhD;Jon C. Montague-Clouse, BS, MS;Brett D. Sahli

August 2nd 2012

Our research focuses on the clinical and economic outcomes of patients receiving care from a payer-designated specialty pharmacy program compared with regular retail pharmacies.

Comparative Effectiveness Research: Is "Synchronicity" a Valid Outcome?

William H. Shrank, MD, MSHS;Niteesh K. Choudhry, MD, PhD

July 14th 2010

Efforts to compare strategies for healthcare delivery must evaluate effectiveness in terms of the outcomes that we care about most.

Setting Prices for Generic Medications: A Survey of Patient's Perceptions

Niteesh K. Choudhry, MD, PhD;Emily R. Cox, PhD;Michael A. Fischer, MD, MS;Jyotsna Mehta, MS;William H. Shrank, MD, MSHS

April 6th 2010

The greater use of generic prescription medications has been widely advocated as a policy solution to rising healthcare costs.

Change We Can Believe In: Requiring Better Evidence for Formulary Coverage

William H. Shrank, MD, MSHS

September 2nd 2009

P&T committees should implement more rigorous formulary restrictions that stimulate manufacturers to meet a higher standard when bringing new therapies to market.